Skip to content

Total Knee Prosthesis With Continuous Block of Adductor Canal and Outcome

Total Knee Arthroplasty & Outcome: A Prospective Randomized Comparison Between Adductor Canal Block and Femoral Nerve Block

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02082067
Enrollment
0
Registered
2014-03-10
Start date
2014-03-31
Completion date
2016-03-31
Last updated
2016-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Knee Arthroplasty

Brief summary

Aim of this study is to evaluate the effects of the adductor canal block on the early and medium term ( 1 month) rehabilitation compared to the continuous femoral block commonly used in the knee prosthesis.

Interventions

PROCEDUREAdductor canal

Perinervous catheter (stimulong sono- Pajunk, Germany) will be insert in adductor canal through tuohy needle (18G, 100mm length) under ultrasound guidance.

PROCEDUREFemoral

Perinervous catheter (stimulong sono- Pajunk, Germany) will be insert between femoral nerve and femoral artery through tuohy needle (18G, 100mm length) under ultrasound guidance.

PROCEDURESpinal Anesthesia

Spinal anesthesia will be perform at L3-L4 or L4-L5 level. Levobupivacaine 0,5% 12mg will be injected.

Continuous infusion of levobupivacaine 0,125% at 8ml/h rate through perinervous catheter until 5th postoperative day.

Ketorolac 30mg 3 times/day and morphine Patients Control Analgesia (1mg/h, max 4mg/h) administered.

DRUGLevobupivacaine 0,125%
DRUGMorphine
DEVICEstimulong sono, Pajunk, Germany

Sponsors

ASST Gaetano Pini-CTO
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients undergoing total knee arthroplasty

Exclusion criteria

* diabetes * neurological disorders * coagulation disorders * rheumatoid arthritis * chronic opioids therapy * allergy to local anesthetic

Design outcomes

Primary

MeasureTime frameDescription
Up and Go test5th postoperative dayKnee functional evaluation at 5th postoperative day. up and go test: time need to get up from a chair, walk for 3 meters, and come back to seat down on the chair

Secondary

MeasureTime frameDescription
VAS scoreup to POD5Evaluation of VAS static and VAS dynamic during hospital stay
Morphine requestup to POD5Opioids consumption will be recorded throughout postoperative period
Range of motion5th postoperative dayPhysiotherapist measures the maximum active/passive range of motion
Falling risk5th postoperative dayEvaluation of falling risk with Berg Balance Scale
Quadriceps strength5th postoperative dayevaluate muscle strength with an isometric force dynamometer to measure the force produced during a maximum voluntary isometric contraction in a lying position by the knee flex to 90°.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026